enGene (ENGN) Short Interest Ratio & Short Volume → Things Are Not Normal in America – Here’s What to Do (From Stansberry Research) (Ad) Free ENGN Stock Alerts $14.67 +0.15 (+1.03%) (As of 11:13 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media enGene Short Interest DataCurrent Short Volume72,700 sharesPrevious Short Volume12,700 sharesChange Vs. Previous Month+472.44%Dollar Volume Sold Short$1.15 millionShort Interest Ratio / Days to Cover1.4Last Record DateApril 15, 2024Outstanding Shares43,580,000 sharesFloat Size7,510,000 sharesShort Percent of Float0.97%Today's Trading Volume5,744 sharesAverage Trading Volume58,410 sharesToday's Volume Vs. Average10% Short Selling enGene ? Sign up to receive the latest short interest report for enGene and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatENGN Short Interest Over TimeENGN Days to Cover Over TimeENGN Percentage of Float Shorted Over Time Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. enGene Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202472,700 shares $1.15 million +472.4%1.0%1.4 $15.79 3/31/202412,700 shares $215,265.00 +54.9%0.2%0.3 $16.95 3/15/20248,200 shares $138,170.00 -82.8%0.1%0.2 $16.85 2/29/202447,600 shares $702,100.00 +957.8%1.8%1.1 $14.75 2/15/20244,500 shares $70,650.00 No Change0.1%0.1 $15.70 1/31/20244,500 shares $35,280.00 No Change0.0%0.1 $7.84 ENGN Short Interest - Frequently Asked Questions What is enGene's current short interest? Short interest is the volume of enGene shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 72,700 shares of ENGN short. 0.97% of enGene's shares are currently sold short. Learn More on enGene's current short interest. What is a good short interest ratio for enGene? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ENGN shares currently have a short interest ratio of 1.0. Learn More on enGene's short interest ratio. What is a good short interest percentage for enGene? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.97% of enGene's floating shares are currently sold short. Is enGene's short interest increasing or decreasing? enGene saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 72,700 shares, an increase of 472.4% from the previous total of 12,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is enGene's float size? enGene currently has issued a total of 43,580,000 shares. Some of enGene's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. enGene currently has a public float of 7,510,000 shares. How does enGene's short interest compare to its competitors? 0.97% of enGene's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to enGene: Arcturus Therapeutics Holdings Inc. (18.77%), Evolus, Inc. (9.57%), Bicycle Therapeutics plc (9.85%), OrthoPediatrics Corp. (6.10%), Phibro Animal Health Co. (3.10%), Pliant Therapeutics, Inc. (12.63%), Disc Medicine, Inc. (14.90%), Mind Medicine (MindMed) Inc. (25.69%), Standard BioTools Inc. (3.05%), Y-mAbs Therapeutics, Inc. (7.04%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short enGene stock? Short selling ENGN is an investing strategy that aims to generate trading profit from enGene as its price is falling. ENGN shares are trading up $0.15 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against enGene? A short squeeze for enGene occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ENGN, which in turn drives the price of the stock up even further. How often is enGene's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENGN, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Arcturus Therapeutics Short Interest Data Evolus Short Interest Data Bicycle Therapeutics Short Interest Data OrthoPediatrics Short Interest Data Phibro Animal Health Short Interest Data Pliant Therapeutics Short Interest Data Disc Medicine Short Interest Data Mind Medicine (MindMed) Short Interest Data Standard BioTools Short Interest Data Y-mAbs Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ENGN) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmith348 million Americans lives to END as we know it?The Oxford ClubUrgent Nvidia WarningAltimetryThe Crypto 9-5 Escape PlanCrypto 101 Media